Pharmacy sales in January-June 2023 increased by 19.4% compared to the same period of 2022 and amounted to almost UAH 84.127 billion.
According to a study by Business Credit, in physical terms, pharmacies sold 612.11 million packs in the first half of this year, which is 10% less than in January-June 2022.
According to the survey, the weighted average price of all goods of the pharmacy basket increased by almost a third (+33%) – up to UAH 137.44. At the same time, pharmacy sales of medicines in January-June 2023 increased to UAH 65.96 billion (+16.9%). The weighted average price of medicines amounted to UAH 153.8, which is 27.2% more than a year earlier. A total of 430.899 mln packs of medicines (-8.12%) were sold in the mentioned reporting period in the pharmacy network.
The report states that pharmacy sales of medical devices increased in the first half of 2023 by 9.83% – up to UAH 2.142 billion.
Among the leaders in terms of growth, in particular, mineral water, whose sales increased by 52.1% to UAH 432.537 million, and dietary supplements with an increase in sales by 51.17% to sales of January-June 2022, almost to UAH 8.453 billion.
At the same time, sales of products for parenteral administration of medicines decreased by 20% to UAH 230.483 mln.
Pharmacy sales in the first quarter of 2023 amounted to 42.3 billion UAH in money terms and 309.8 million packs in kind, the Business Credit company told the agency.
At the same time, according to the company, in the fourth quarter of 2022 pharmacy sales of 39.5 billion UAH or 308.7 million packs.
The sales increase in monetary terms the company’s analysts explain the growth in weighted average retail price – for three months the average price of goods rose by 8.3 UAH.
In monetary terms the leaders of pharmacy sales turnover in the first quarter were mineral water (+17.3%). At the same time the prices in this group of goods rose by 9.45%. In addition, among the leaders of turnover were dietary supplements (+13.6%), with prices up 5.1% and demand up 8%.
The medicinal cosmetics segment (10.5%) grew in monetary terms in the first quarter of 2023.
In other product groups, the turnover in the first quarter increased slower than the market, or declined at all.
At the same time, the company’s analysts forecast growth of turnover in pharmacy sales due to inflation, rising prices and changes in consumption patterns amid stagnating consumer demand.
At the same time, according to the company, by the end of 2022 the retail pharmacy sales fell by 9.7% in volume terms to 1.2 billion units against 1.417 billion in 2021.
In monetary terms, pharmacy sales in 2022 rose 13.4% to 143.2 billion.
“The increase in turnover in monetary terms was primarily due to high inflation. In the structure of pharmacy sales, inflation was 18% on the background of retail price growth (25.6%). Own price growth led to an increase in turnover in monetary terms against the background of falling consumer demand,” the company states.
